✦ LIBER ✦

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

✍ Scribed by Sven-Eric Olsson; Luisa L. Villa; Ronaldo L.R. Costa; Carlos A. Petta; Rosires P. Andrade; Christian Malm; Ole-Erik Iversen; John Høye; Margareta Steinwall; Grete Riis-Johannessen; Agneta Andersson-Ellstrom; Kristina Elfgren; Geo von Krogh; Matti Lehtinen; Jorma Paavonen; Gretchen M. Tamms; Katherine Giacoletti; Lisa Lupinacci; Mark T. Esser; Scott C. Vuocolo; Alfred J. Saah; Eliav Barr

Book ID: 116959730
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 442 KB
Volume: 25
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2007.03.049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of co-administ

Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines

✍ Cosette M. Wheeler; Oliver M. Bautista; Joanne E. Tomassini; Margaret Nelson; Ca 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 344 KB

Impact of a prophylactic quadrivalent hu

Impact of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle vaccine in a sexually active population of North American women

✍ Eliav Barr; Christine K. Gause; Oliver M. Bautista; Radha A. Railkar; Lisa C. Lu 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 185 KB

PS10 Late breaking Prophylactic use of q

PS10 Late breaking Prophylactic use of quadrivalent human papillomavirus (HPV) (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine reduces cervical intraepithelial neoplasia (CIN) 2/3 and adenocarcinoma in situ (AIS) risk

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Safety, immunogenicity, and efficacy of

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women

✍ Gonzalo Perez; Eduardo Lazcano-Ponce; Mauricio Hernandez-Avila; Patricia J. Garc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 103 KB

## Abstract The prevalence of HPV infection in Latin America is among the highest in the world. A quadrivalent (types 6/11/16/18) human papillomavirus L1 virus‐like‐particle vaccine has been shown to be 95–100% effective in preventing HPV 6/11/16/18‐related cervical and genital disease in women naï

The impact of a quadrivalent human papil

The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24

✍ S Majewski; FX Bosch; J. Dillner; O-E Iversen; SK Kjaer; N Muñoz; S-E Olsson; J 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Prophylactic quadrivalent human papillom

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

✍ Luisa L Villa; Ronaldo LR Costa; Carlos A Petta; Rosires P Andrade; Kevin A Ault 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 109 KB